Advancing age is the major risk factor for the development of CVD (cardiovascular
diseases). This is attributable, in part, to the development of vascular endothelial …

Background Hormone therapy (HT) is widely used for controlling menopausal symptoms
and has also been used for the management and prevention of cardiovascular disease …

Estrogen is a potent steroid with pleiotropic effects, which have yet to be fully elucidated.
Estrogen has both nuclear and non-nuclear effects. The rapid response to estrogen, which …

Aim: To quantify the effects of hormone‐replacement therapy (HRT) on components of the
metabolic syndrome in postmenopausal women. Methods: Comprehensive searches of …

Over the past decade, clinical and basic research has demonstrated that estrogen has a
dramatic impact on the response to vascular injury and the development of atherosclerosis …

ContextRaloxifene, a selective estrogen receptor modulator, improves cardiovascular risk
factors, but its effect on cardiovascular events is unknown. ObjectiveTo determine the effect …

Despite significant decreases in cardiovascular disease (CVD) mortality in the past three
decades, it still remains the leading cause of death in women. Following menopause and …

Objectives: The goal of this study was to determine the influence of gender on baseline
characteristics, response to treatment, and prognosis in patients with heart failure (HF) and …

Objectives: We assessed the clinical efficacy of single-site left ventricular (LV) pacing and
determined the impact of baseline conduction delay severity on the magnitude of benefit …

OBJECTIVE: To assess mortality associated with hormone replacement in younger and
older postmenopausal women. DESIGN: A comprehensive search of medline, cinahl, and …